Spravato Essentials
Why Spravato® The STAR*D trial demonstrated that the more antidepressants a patient trial’s the less likely they are to respond overall. By the point a patient tries 3 antidepressant’s the remission rate is only about 15% with another treatment trial. Of the patient’s who respond remit at level 3 of 4, 60-70% will relapse within […]
